Medical technology company EVYD Technology and the Agency for Science, Technology and Research, Singapore’s leading R&D agency, have established a joint AI research lab focusing on public health and technical health. digital.
At the same time, they announced a S$10 million (US$7.5 million) project in a joint laboratory to facilitate cross-border, multi-institutional cooperation in the field of medical technology. digital.
WHAT IT’S ABOUT
According to the press release, A*STAR-EVYD Joint Labs will apply AI to address industry-specific challenges to population health and digital health..
First, it seeks to encourage the adoption of healthy habits by developing a collection of health data and health scores, backed by behavioral science.
The lab will also explore a wellness service that uses large language models in a healthcare context; use remote health monitoring for early disease detection; and streamline the diagnostic process to assist clinicians in data interpretation and diagnostic evaluation.
Moreover, it will pilot testing and implementing artificial intelligence-based medical data processing and medical data security technologies for proven real-world applications outside of a laboratory environment. It will also host seminars, talks or conferences to facilitate knowledge sharing among healthcare communities.
WHY IT IMPORTANT
A key commitment of this new AI lab is S$10 million The project aims to address regulatory challenges and concerns related to inter-regional data sharing to enable cross-border, cross-organizational collaboration in the field of digital health. Led by A*STAR’s Institute for High Performance Computing, the project will incorporate secure data technologies to enable healthcare organizations to keep sensitive data in their IT infrastructure. them, thus enabling national and international healthcare providers, research institutions and healthcare companies to collaborate. create innovative healthcare solutions.
TREND TO BIGGER
Last year, A*STAR entered into a similar partnership to promote digital health collaboration. It signed a Memorandum of Understanding with Johnson & Johnson Vision to form a consortium focused on digital innovations in eye health. Over three years, it will leverage public-private partnerships to advance eye health research and solutions to eye health problems in the Asia-Pacific region. Emerging technologies, such as blockchain and AI, and data privacy protection techniques will also be leveraged to establish trusted data access and enable data sharing between members of the corporation.
ON PROFILE
“The establishment of the A*STAR-EVYD Joint Laboratory will serve as a dynamic platform to foster collaboration with the healthcare community and facilitate cross-industry partnerships. Together, we will work towards artificial intelligence-based digital health solutions that can enhance patient outcomes for patients Lim Keng Hui, professor and assistant executive director of the Research Institute. Science and Engineering Research A*STAR said: Council.
“The A*STAR-EVYD Joint Laboratories is a strategic partnership with enormous potential to transform patient outcomes on a global scale. By leveraging the [AI]Advanced data processing and privacy protection technology, A*STAR’s EVYD Technology and IHPC aim to push the boundaries of what is achievable in terms of population health and digital health. ,” EVYD Technology CEO Ming Jie Chua also commented.
